Drug Shortage Report for MYLAN-HYDROXYUREA
Report ID | 100921 |
Drug Identification Number | 02242920 |
Brand name | MYLAN-HYDROXYUREA |
Common or Proper name | HYDROXYUREA |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROXYUREA |
Strength(s) | 500MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100BT |
ATC code | L01XX |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-11-29 |
Estimated end date | 2020-06-02 |
Actual end date | 2020-06-02 |
Shortage status | Resolved |
Updated date | 2020-06-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.